NIH #R01CA285851
Harnessing DNA methylation in peripheral blood for improved colorectal cancer prevention
Active
- Amount
- $700K–$800K
- Period
- 2024-08-01 → 2028-07-31
- PIs
- 2
Awarded at HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH
Marios Giannakis
Full Professor(heuristic)
Cancer Genomics and Diagnostics · Cancer Research
Compare more Cancer Research professors.
h-index55
i10-index123
Publications785
Citations17,020
Grants
2 total · 1 active
NIH #R21CA222940
Integrating diet and tissue whole exome sequencing data to study processed meat and colorectal cancer
- Amount
- $100K–$200K
- Period
- 2018-01-01 → 2020-12-31
- PIs
- 2
Awarded at HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Figure S1 from A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer2026-06-17
- New NIH award: Harnessing DNA methylation in peripheral blood for improved colorectal cancer prevention2024-08-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current
Find elsewhere
ORCID: 0000-0001-9012-6982